Table 1.
Antiretroviral Therapy Policies in 99 Countries
| CD4 Count Policy, Cells/µL | 2004–2005 | 2006–2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 |
|---|---|---|---|---|---|---|---|---|
| Irrespective of CD4 count | Netherlands, DHHS | Australia, Brazil, France, South Korea | Spain, Thailand | |||||
| ≤500 (consider for ≥500) | DHHS | Italy | Argentina | Hong Kong | ||||
| ≤500 | Algeria | WHO, Bolivia, Ecuador, Ethiopia, Honduras, Madagascar, Mali, Oman, Rwanda, Tunisia, Uganda, Zambia, Zimbabwe | WHO, Bangladesh, El Salvador, Gabon, Kenya, Lesotho, Malawi, Mauritania, Myanmar, Namibia, Nepal, South Africa, South Sudan, Sri Lanka, Sudan, Venezuela, | |||||
| ≤350 (consider for ≤500) | Guyanaa | Uruguay, Guinea | Austriaa, Belize, Germanya, Mexico | Costa Rica | ||||
| ≤350 | Djibouti, Sierra Leone | Burkina Faso, Canada, Moldova, Niger, Papua New Guinea, Nicaragua, Sweden | WHO, Burundi, Chile, Democratic Republic of Congo, Ghana, Morocco, Nigeria, Swaziland | WHO, Angola, Haiti, Indonesia, Jamaica, Kazakhstan, Malaysia, Panama, Paraguay, Switzerland, Vietnam | WHO, Botswana, Benin, Cambodia, China, Guatemala, Peru, Mozambique, Tanzania | Great Britain, Dominican Republic, India | ||
| ≤250 (consider for ≤350) | Colombia | |||||||
| ≤200 (consider for ≤350) | Cape Verde | WHO, Afghanistan, Russia, Ukraine | WHO, Cuba | |||||
| ≤200 | WHO, Cote d'Ivoire, Pakistan | Bhutan, Comoros, Lao People's Democratic Republic, Liberia | Philippines | Cameroon |
The list is updated as of April 2015 and is contingent upon publication of national guidelines. Countries listed in italics are consistent with WHO guidelines in a given year; countries listed in bold recommend early antiretroviral therapy (ART) compared with the WHO recommendation.
Abbreviations: DHHS, US Department of Health and Human Services; WHO, World Health Organization.
a Austria, Germany, and Guyana additionally recommend considering ART at CD4 count ≥500 cells/µL.